Navigation Links
Top-Line Data Available from Three Ipilimumab Pivotal Trials in Patients with Advanced Metastatic Melanoma
Date:12/10/2007

relations department.

About Bristol-Myers Squibb

Bristol-Myers Squibb is dedicated to the discovery, development and exhaustive exploration of innovative cancer fighting therapies designed to extend and enhance the lives of patients living with cancer. More than 40 years ago, Bristol-Myers Squibb built a unified vision for the future of cancer treatment. With expertise, dedication and resolve, that vision led to the development of a diverse global portfolio of anti-cancer therapies that are an important cornerstone of care today. Hundreds of scientists in Bristol-Myers Squibb's Research and Development organization are studying ways to improve current cancer treatments and identify better, more effective medicines for the future.

Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.

This press release contains "forward-looking statements" as that term is defined in the Private Securities Litigation Reform Act of 1995, regarding the development of biological products and the submission of applications to market such products. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Among other risks, there can be no guarantee that the development of the product described in this release will be successful or that the clinical studies described in this release will support the filing of a Biological License Application (BLA) with the U.S. Food and Drug Administration (FDA). Furthermore, there can be no assurances that if a BLA is filed with the FDA, that it will be filed in the timeframe described in this release or that the BLA for the product described in this release will receive regulatory appro
'/>"/>

SOURCE Bristol-Myers Squibb Company; Medarex, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
2. College Mental Health Expert and Sister of Student Who Died By Suicide Available to Discuss College Mental Health Issues
3. Multi-Year Compendium of Pharmaceutical Case Studies Available from Best Practices, LLC
4. Tickets Still Available for Detroit Uncorked;
5. Proven Terumo Coronary Guidewire Technology Is Now Available in the United States
6. Experts, Advocates Available to Comment on Hillary Clintons Health Care Plan
7. Fingertip Formulary Mobile(TM) is Now Available for Physicians and Other Healthcare Providers Free on PDAs
8. New Resource for Taking Care of Aging Parents Available in Beta
9. 2007/2008 Pharmaceutical R&D Factbook Published by CMR International is Now Available
10. Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies
11. Updated Brochure on Gynecologic Cancer Treatments Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... (PRWEB) , ... July 01, ... ... in the communities of southeast Alabama, southwest Georgia and the Florida Panhandle, ... TelmedIQ as its primary secure text messaging and clinical communications workflow solution ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... the legal medical cannabis space, created a web-based resource where legal cannabis ... Harvest Financial brings together visionary entrepreneurs and medical marijuana advocates looking to strategically ...
(Date:7/1/2015)... ... ... Effective June 9, 2015, the Radiology Business Management Association (RBMA) ... process has been in place since the RBMA was founded in 1968 with all ... succeeds Keith E. Chew, MHA, CMPE, as president. Ms. Taylor has been an RBMA ...
(Date:6/30/2015)... , ... July 01, 2015 , ... Carey Danis ... lawsuits being managed in a West Virginia federal court. The court document outlined ... trial date for the 26 cases.¹ , Carey Danis & Lowe is a personal ...
(Date:6/30/2015)... ... ... Down is a reputable source of authentic Kid Rock tickets at the DTE Energy ... road again this summer in what is one of the most affordable summer tours in ... this year at the XFINITY Theatre in Hartford, CT on June 24th and the blockbuster ...
Breaking Medicine News(10 mins):Health News:Southeast Alabama Community Health System Chooses TelmedIQ to Meet Secure Text Messaging Challenges for Healthcare 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 2Health News:First Harvest Financial Partners in Launch of Legal Medical Cannabis Documentary Initiative 3Health News:Radiology Business Management Association Announces Board of Directors and Officers for 2015-2016 2Health News:Radiology Business Management Association Announces Board of Directors and Officers for 2015-2016 3Health News:Radiology Business Management Association Announces Board of Directors and Officers for 2015-2016 4Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 3Health News:Cheap Kid Rock Tickets at the DTE Energy Music Theatre in Clarkston: Ticket Down Has Slashed Prices On All Kid Rock Tickets at DTE in the Detroit Metro Area 2
... 2,000,000 Minnesotans have designated their wishes to donate,on their ... April 1, 2008 When,Minnesotans apply for or renew ... with the opportunity to check the,box designating themselves organ ... taken that important step and said yes to the,life-saving ...
... CA, April 1, 2008 Rap music has gone from ... substance abuse to one that often glorifies illegal drug use, ... genre covering nearly two decades. The study is published ... a peer reviewed scientific journal., Positive portrayals of drug use ...
... protein helps virus conceal itself from body,s defenses , , ... discovered how HIV -- the virus that causes AIDS -- ... body,s immune cells. , They explained that when a normal ... immune system responds and produces cells that quickly eliminate the ...
... With Melanin-Rich Skin Tones, SKILLMAN, N.J., April 1, 2008 ... skin tones between,the ages of 25 and 54 experience dry ... only skin concern for these women. Women with,richer skin tones ... due to the excess melanin in their skin that often ...
... NEW YORK, April 1 SpongeTech Delivery,Systems, Inc. ... Darryl,Strawberry Foundation are pleased to announce corporate involvement ... for the New,York Mets, I am excited about ... have been a great tool for children with,autism, ...
... April 1, 2008 Valensa International,introduced Crannose(TM) ... Natural Products Expo West Conference. This patent-pending,supplement, ... known benefits of cranberry with D-mannose, a ... Larch tree. The,product is available in bulk, ...
Cached Medicine News:Health News:Minnesotans Demonstrate Commitment to Organ and Tissue Donation 2Health News:Drug use increasingly glamorized in rap music, according to new study of 2-decade trends 2Health News:Drug use increasingly glamorized in rap music, according to new study of 2-decade trends 3Health News:Scientists Uncover How HIV Hides Inside Cells 2Health News:AMBI(R) Introduces SOFT & EVEN(TM) 2Health News:AMBI(R) Introduces SOFT & EVEN(TM) 3Health News:SpongeTech Delivery Systems, Inc. to Donate to The Darryl Strawberry Foundation!! 2Health News:Crannose(TM) Extra Strength Women's Health Formula Targets Urinary Tract Infections 2
(Date:6/30/2015)... 30, 2015 Oramed Pharmaceuticals Inc. ... pharmaceutical Company focused on the development of oral drug ... been screened in the Company,s Phase IIb trial of ... will be performed under the active Investigational New Drug ... Drug Administration (FDA). The Phase IIb study ...
(Date:6/30/2015)... , June 30, 2015  July 4 th ... of independence, and the spirit and people behind it. To ... has partnered with USA Medical Card, ... increase funding for programs that empower independence for our disabled ... and help more people afford their prescriptions. "Due ...
(Date:6/30/2015)... June 30, 2015  EnteroMedics Inc. (NASDAQ: ETRM ... neuroblocking technology to treat obesity, metabolic diseases, and other ... public offering  of 40,229,886 units. Each unit consists of ... A warrant to purchase one share of common stock, ... one share of common stock, at a purchase price ...
Breaking Medicine Technology:Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 2Oramed Enrolls First Patient in its Phase IIb Oral Insulin Study 3Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 2EnteroMedics Inc. Announces Pricing of $35.0 Million Public Offering of Common Stock and Warrants 3
... 3 Australian researchers have developed gene expression ... colorectal growths from non-cancerous controls. , , ... conference in Chicago, the preliminary findings are the ... Flinders University and Australian healthcare company, Clinical Genomics ...
... Day 3 And All Subsequent Study Visits - , ... Pharma Co., Ltd., (DSP) announced today that positive results from ... of patients with schizophrenia have been published in The ... placebo-controlled trial, involving 180 patients with acute schizophrenia, evaluated a ...
Cached Medicine Technology:Advance in Bowel Cancer Test Research 2Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 2Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 3Study Demonstrating Lurasidone Is Effective in Patients With Schizophrenia Published in The Journal of Clinical Psychiatry 4
Used for internal biliary drainage. Supplied sterile in peel-open packages. Intended for one-time use....
... Marker directly to the biopsy site helps ... performed. ,The MICROMARK® II Tissue Marker is ... for use with the MAMMOTOME Biopsy System. ... site after a biopsy with the MAMMOTOME ...
... wrap than VICRYL knitted mesh. Especially suitable ... contained. Predictable absorption. Polyglactin 910 has been ... ,VICRYL (polyglactin 910) woven mesh is prepared ... and lactide, derived respectively from glycolic and ...
Used for implantation to reinforce soft tissue. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: